The Claim
Administration of insulin therapy to pediatric patients with type 1 diabetes is associated with decreased serum melatonin concentrations, potentially mediated by antagonistic interactions at G-protein-coupled receptors, indicating a bidirectional hormonal interplay in metabolic regulation.
What the research says
Challenges is higher
Challenge is ahead, but a single strong supporting study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Giving insulin to kids with type 1 diabetes seems to lower their melatonin levels. This might happen because insulin and melatonin compete for the same receptors in the body, showing how these two hormones work together to control metabolism.
See the scientific wording
Insulin therapy in pediatric type 1 diabetes is associated with reduced serum melatonin concentrations, potentially due to melatonin-insulin antagonism at G-protein-coupled receptors, suggesting a bidirectional hormonal interplay in metabolic regulation.
What the research says
1 studyThe authors discuss documented melatonin-insulin antagonism from animal and human studies to explain the observed melatonin deficiency, but the current study only measures melatonin and does not correlate it with insulin dosage or test the mechanism directly. This represents a literature-based hypothesis rather than primary data, highlighting a potential pathway for future mechanistic research.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.